Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:71258rdf:typepubmed:Citationlld:pubmed
pubmed-article:71258lifeskim:mentionsumls-concept:C1514521lld:lifeskim
pubmed-article:71258lifeskim:mentionsumls-concept:C0007737lld:lifeskim
pubmed-article:71258lifeskim:mentionsumls-concept:C0012222lld:lifeskim
pubmed-article:71258lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:71258pubmed:issue34lld:pubmed
pubmed-article:71258pubmed:dateCreated1977-11-25lld:pubmed
pubmed-article:71258pubmed:abstractTextAfter i.v.-application of 2 grams of Cephaprin (= Bristocef) to 13 patients with prostatic adenoma the mean serum concentrations after 30 minutes were 50 microgram/ml and 21.5 microngram/ml after 60 minutes. The corresponding tissue values were 20.8 and microgram/g respectively in prostatic tissue. The evaluated serumand tissue cncentrations are suited to the therapy of infections with cephapirin sensitive rods.lld:pubmed
pubmed-article:71258pubmed:languagegerlld:pubmed
pubmed-article:71258pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:71258pubmed:citationSubsetIMlld:pubmed
pubmed-article:71258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:71258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:71258pubmed:statusMEDLINElld:pubmed
pubmed-article:71258pubmed:monthSeplld:pubmed
pubmed-article:71258pubmed:issn0015-8178lld:pubmed
pubmed-article:71258pubmed:authorpubmed-author:StaehlerGGlld:pubmed
pubmed-article:71258pubmed:authorpubmed-author:AdamDDlld:pubmed
pubmed-article:71258pubmed:authorpubmed-author:HofstetterA...lld:pubmed
pubmed-article:71258pubmed:issnTypePrintlld:pubmed
pubmed-article:71258pubmed:day15lld:pubmed
pubmed-article:71258pubmed:volume95lld:pubmed
pubmed-article:71258pubmed:ownerNLMlld:pubmed
pubmed-article:71258pubmed:authorsCompleteYlld:pubmed
pubmed-article:71258pubmed:pagination2107-9lld:pubmed
pubmed-article:71258pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-Hu...lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-In...lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-Ag...lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-Pr...lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-Ma...lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-Pr...lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-Ti...lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-Ce...lld:pubmed
pubmed-article:71258pubmed:meshHeadingpubmed-meshheading:71258-Ce...lld:pubmed
pubmed-article:71258pubmed:year1977lld:pubmed
pubmed-article:71258pubmed:articleTitle[Studies on the diffusion of cephapirin into prostatic tissue].lld:pubmed
pubmed-article:71258pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:71258pubmed:publicationTypeEnglish Abstractlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:71258lld:pubmed